Mesoblast, Inc.

Quick facts

Phase 3 pipeline

• Prochymal® · Immunology
  Prochymal is a mesenchymal stem cell therapy that aims to modulate the immune system and promote tissue repair.
• Standard of Care for GVHD · Immunology
  Rexlemestrocel-L is a mesenchymal stem cell therapy that modulates the immune system to treat graft-versus-host disease.

Phase 2 pipeline

• adult human mesenchymal stem cells

Phase 1 pipeline

• Provacel · Other

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Mesoblast, Inc. portfolio CI brief
• Mesoblast, Inc. pipeline updates RSS